Massimo Offidani

23PUBLICATIONS

75CO-AUTHORS

HaematologyMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRegenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jun 23, 2026

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.

|Nov 13, 2025

The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?

Sonia Morè, Massimo Offidani, Laura Corvatta

|Aug 14, 2025

Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. <i>Cancers</i> 2025, <i>17</i>, 1168.

Katia Mancuso, Simona Barbato, Francesco Di Raimondo

|Apr 14, 2025

Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma.

Katia Mancuso, Simona Barbato, Francesco Di Raimondo

|Mar 19, 2025

Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.

Fortunato Morabito, Enrica Antonia Martino, Monica Galli

|Feb 13, 2025

Long-Term Survival with Multiple Myeloma: An Italian Experience.

Francesca Fazio, Martina Gherardini, Elena Rossi

Pageof 4

Frequent Collaborators

6 joint publications

Maria Teresa Petrucci

Katia Mancuso

Francesca Gay

Francesca Fazio

Emiliano Barbieri

Pellegrino Musto

Antonella Bruzzese

Elena Zamagni

Renato Zambello

Pieter Sonneveld

Frequent Collaborators

6 joint publications

Maria Teresa Petrucci

4 joint publications

Katia Mancuso

4 joint publications

Francesca Gay

3 joint publications

Francesca Fazio